StockData
MTEXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

MANNATECH INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$8.74+1.62 (+22.67%)

Close on Oct 19, 2026

Market cap
$16.87M
P/E (TTM)
–
Dividend yield
–

MANNATECH INC revenue by segment

By business segment

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Product [Member]$26.20M$24.50M$26.10M$28.70M$25.20M$26.10M$28.60M$31.30M––––98.3%+4.0%
Product and Service, Other [Member]$400.00K$300.00K$400.00K$400.00K$400.00K$400.00K$300.00K$300.00K––––1.5%0.0%
Associate Service Fees [Member]$100.00K$100.00K$100.00K$100.00K$100.00K$100.00K$100.00K$100.00K––––0.4%0.0%
Consolidated pack sales and associate fees–––––$700.00K$700.00K$1.30M$1.00M$1.10M$900.00K$1.20M––
Other–––––$400.00K$300.00K$300.00K$400.00K$400.00K$400.00K$400.00K––
Product sales–––––$25.50M$28.00M$30.10M$26.30M$27.90M$31.40M$31.00M––

By region

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Asia Pacific [Member]–––––$15.40M–$18.60M$15.90M$17.10M–$19.60M––
EMEA [Member]–––––$2.20M–$2.50M$2.30M$2.10M–$2.30M––
Americas [Member]–––––$9.00M–$10.60M$9.50M$10.20M–$10.70M––

From the segment and revenue-disaggregation notes of Mannatech's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.